Phase II clinical trial of nirogacestat in patients with relapsed ovarian granulosa cell tumours.

Grisham RN, Hopp E, Pennington K, Holloway R, Wenham RM, Blecharz P, Dockery L, Matsuo K, Salani R, Bidzinski M, Braly P, Celano P, Reid T, Seward S, Lewis J, Johnson M, DuBose R, Ahn S, Cheng S, Alvero C, Konstantinopoulos PA

Open source

DOI: 10.1002/ctm2.70568
Published: 2026 Jan
Container: Clinical and translational medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/ctm2.70568,
  title = {Phase II clinical trial of nirogacestat in patients with relapsed ovarian granulosa cell tumours.},
  author = {Grisham RN and Hopp E and Pennington K and Holloway R and Wenham RM and Blecharz P and Dockery L and Matsuo K and Salani R and Bidzinski M and Braly P and Celano P and Reid T and Seward S and Lewis J and Johnson M and DuBose R and Ahn S and Cheng S and Alvero C and Konstantinopoulos PA},
  year = {2026},
  journal = {Clinical and translational medicine},
  doi = {10.1002/ctm2.70568},
  url = {https://doi.org/10.1002/ctm2.70568}
}

RIS

TY  - JOUR
TI  - Phase II clinical trial of nirogacestat in patients with relapsed ovarian granulosa cell tumours.
AU  - Grisham RN
AU  - Hopp E
AU  - Pennington K
AU  - Holloway R
AU  - Wenham RM
AU  - Blecharz P
AU  - Dockery L
AU  - Matsuo K
AU  - Salani R
AU  - Bidzinski M
AU  - Braly P
AU  - Celano P
AU  - Reid T
AU  - Seward S
AU  - Lewis J
AU  - Johnson M
AU  - DuBose R
AU  - Ahn S
AU  - Cheng S
AU  - Alvero C
AU  - Konstantinopoulos PA
PY  - 2026
JO  - Clinical and translational medicine
DO  - 10.1002/ctm2.70568
UR  - https://doi.org/10.1002/ctm2.70568
ER  -

APA

RN, G., E, H., K, P., R, H., RM, W., P, B., L, D., K, M., R, S., M, B., P, B., P, C., T, R., S, S., J, L., M, J., R, D., S, A., S, C., C, A., & PA, K. (2026). Phase II clinical trial of nirogacestat in patients with relapsed ovarian granulosa cell tumours.. Clinical and translational medicine. https://doi.org/10.1002/ctm2.70568

Source records

pubmed · retrieved 2026-09-25T23:35:36.399Z